SMTL ID : 4dbu.2 (1 other biounit)

Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3-((4 -(trifluoromethyl)phenyl)amino)benzoic acid

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

monomer

Ligands

1 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NAP.1: 29 residues within 4Å: Chain A: G.22, T.23, Y.24, D.50, Y.55, K.84, H.117, S.166, N.167, Q.190, Y.216, S.217, A.218, L.219, G.220, S.221, Q.222, L.236, A.253, L.268, A.269, K.270, S.271, Y.272, N.273, R.276, Q.279, N.280 Ligands: BT9.2 27 PLIP interactions: 27 interactions with chain A Hydrogen bonds: A:G.22, A:T.23, A:Y.24, A:S.166, A:N.167, A:Q.190, A:S.217, A:L.219, A:S.221, A:Q.222, A:Q.222, A:L.268, A:K.270, A:S.271, A:S.271, A:Y.272, A:Q.279, A:N.280 Water bridges: A:S.217, A:A.218, A:A.218, A:S.221, A:Q.279 Salt bridges: A:K.270, A:R.276 pi-Stacking: A:Y.216 pi-Cation interactions: A:R.276

1 x BT9: 3-{[4-(trifluoromethyl)phenyl]amino}benzoic acid(Non-covalent)

BT9.2: 13 residues within 4Å: Chain A: Y.24, L.54, Y.55, H.117, S.118, M.120, N.167, Y.216, W.227, F.306, P.318, Y.319 Ligands: NAP.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.54 Hydrogen bonds: A:Y.55 Salt bridges: A:K.84, A:H.117 pi-Stacking: A:Y.24, A:W.227, A:F.306 Halogen bonds: A:S.118

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, M. et al., Crystal structures of AKR1C3 containing an N-(aryl)amino-benzoate inhibitor and a bifunctional AKR1C3 inhibitor and androgen receptor antagonist. Therapeutic leads for castrate resistant prostate cancer. Bioorg.Med.Chem.Lett. (2012)

Release Date

2012-03-28

Peptides

Aldo-keto reductase family 1 member C3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Aldo-keto reductase family 1 member C3

Related Entries With Identical Sequence